Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Identification of a Novel 29-Gene-Based Subtype of Hepatocellular Carcinoma and Its Correlation With Immunotherapy Efficacy

NCT07100236 is registered in ClinicalTrials.gov with Junjie Xu as lead sponsor.

NCT NCT07100236
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07100236 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Identification of a Novel 29-Gene-Based Subtype of Hepatocellular Carcinoma and Its Correlation With Immunotherapy Efficacy
Lead sponsor
Junjie Xu
Phase
Observational
Overall status
Not yet recruiting
Start date
August 1, 2025
Completion date
August 1, 2027
Enrollment
350 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

primary hepatocellular carcinoma